382 related articles for article (PubMed ID: 9514656)
21. Regulation of rat hepatic cytochrome P450 expression by sterol biosynthesis inhibition: inhibitors of squalene synthase are potent inducers of CYP2B expression in primary cultured rat hepatocytes and rat liver.
Kocarek TA; Kraniak JM; Reddy AB
Mol Pharmacol; 1998 Sep; 54(3):474-84. PubMed ID: 9730906
[TBL] [Abstract][Full Text] [Related]
22. Quercetin regulates hepatic cholesterol metabolism by promoting cholesterol-to-bile acid conversion and cholesterol efflux in rats.
Zhang M; Xie Z; Gao W; Pu L; Wei J; Guo C
Nutr Res; 2016 Mar; 36(3):271-9. PubMed ID: 26923514
[TBL] [Abstract][Full Text] [Related]
23. Physiological feedback regulation of cholesterol biosynthesis: Role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols.
Ness GC
Biochim Biophys Acta; 2015 May; 1851(5):667-73. PubMed ID: 25701719
[TBL] [Abstract][Full Text] [Related]
24. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.
Petras SF; Lindsey S; Harwood HJ
J Lipid Res; 1999 Jan; 40(1):24-38. PubMed ID: 9869647
[TBL] [Abstract][Full Text] [Related]
25. Translational regulation of hepatic HMG-CoA reductase by dietary cholesterol.
Chambers CM; Ness GC
Biochem Biophys Res Commun; 1997 Mar; 232(2):278-81. PubMed ID: 9125163
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
27. Mevalonic acid-dependent degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in vivo and in vitro.
Correll CC; Edwards PA
J Biol Chem; 1994 Jan; 269(1):633-8. PubMed ID: 8276863
[TBL] [Abstract][Full Text] [Related]
28. Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-beta protein precursor processing by suppression of cholesterol synthesis.
Kojro E; Füger P; Prinzen C; Kanarek AM; Rat D; Endres K; Fahrenholz F; Postina R
J Alzheimers Dis; 2010; 20(4):1215-31. PubMed ID: 20413873
[TBL] [Abstract][Full Text] [Related]
29. Effects of HMG-CoA reductase inhibition on hepatic expression of key cholesterol-regulatory enzymes and receptors in nephrotic syndrome.
Vaziri ND; Liang K
Am J Nephrol; 2004; 24(6):606-13. PubMed ID: 15583480
[TBL] [Abstract][Full Text] [Related]
30. SC-435, an ileal apical sodium-codependent bile acid transporter inhibitor alters mRNA levels and enzyme activities of selected genes involved in hepatic cholesterol and lipoprotein metabolism in guinea pigs.
West KL; McGrane M; Odom D; Keller B; Fernandez ML
J Nutr Biochem; 2005 Dec; 16(12):722-8. PubMed ID: 16169202
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis.
Vaziri ND; Sato T; Liang K
Kidney Int; 2003 May; 63(5):1756-63. PubMed ID: 12675851
[TBL] [Abstract][Full Text] [Related]
32. Discordant regulation of proteins of cholesterol metabolism during the acute phase response.
Feingold KR; Pollock AS; Moser AH; Shigenaga JK; Grunfeld C
J Lipid Res; 1995 Jul; 36(7):1474-82. PubMed ID: 7595071
[TBL] [Abstract][Full Text] [Related]
33. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
34. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.
Bergstrom JD; Dufresne C; Bills GF; Nallin-Omstead M; Byrne K
Annu Rev Microbiol; 1995; 49():607-39. PubMed ID: 8561474
[TBL] [Abstract][Full Text] [Related]
35. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by mevalonate.
Straka MS; Panini SR
Arch Biochem Biophys; 1995 Feb; 317(1):235-43. PubMed ID: 7872789
[TBL] [Abstract][Full Text] [Related]
36. Gene expression of LDL receptor, HMG-CoA reductase, and cholesterol-7 alpha-hydroxylase in chronic renal failure.
Liang K; Vaziri ND
Nephrol Dial Transplant; 1997 Jul; 12(7):1381-6. PubMed ID: 9249773
[TBL] [Abstract][Full Text] [Related]
37. Mechanism for control of hydroxymethylglutaryl-coenzyme A reductase and cytochrome P-450 side chain cleavage message and enzyme in the corpus luteum.
Puryear TK; McLean MP; Khan I; Gibori G
Endocrinology; 1990 Jun; 126(6):2910-8. PubMed ID: 2351103
[TBL] [Abstract][Full Text] [Related]
38. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
39. The physiological role of sterol regulatory element-binding protein-2 in cultured human cells.
Kawabe Y; Suzuki T; Hayashi M; Hamakubo T; Sato R; Kodama T
Biochim Biophys Acta; 1999 Jan; 1436(3):307-18. PubMed ID: 9989262
[TBL] [Abstract][Full Text] [Related]
40. Differing effects of cholesterol and taurocholate on steady state hepatic HMG-CoA reductase and cholesterol 7 alpha-hydroxylase activities and mRNA levels in the rat.
Shefer S; Nguyen LB; Salen G; Ness GC; Chowdhary IR; Lerner S; Batta AK; Tint GS
J Lipid Res; 1992 Aug; 33(8):1193-200. PubMed ID: 1431598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
